Four notes on Zimmer Biomet’s first quarter financial results:
1. Zimmer Biomet’s net sales from continuing operations saw a 3.9 percent increase from the first quarter of 2021, the company said May 3.
2. The company saw $73 million in net earnings from continuing operations.
3. Diluted earnings per share from continuing operations for the company were $0.35.
4. Zimmer Biomet also completed the spinoff of ZimVie, its spine and dental business, in March.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
